COMPASS THERAPEUTICS, INC. Other Accrued Liabilities, Current
COMPASS THERAPEUTICS, INC. (CMPX) had Other Accrued Liabilities, Current of $1.18 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Accrued Liabilities, Current
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Other Accrued Liabilities, Current $1.18M.
- 2026-03-31: Other Accrued Liabilities, Current $708.00K.
- 2025-12-31: Other Accrued Liabilities, Current $484.00K.
- 2025-09-30: Other Accrued Liabilities, Current $141.00K.
| Period end | Other Accrued Liabilities, Current | Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.18M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $708.00K 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $484.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $141.00K 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $384.00K 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $274.00K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $621.00K 10-K · filed 2026-03-05 | |
| 2024-09-30 | $167.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $308.00K 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $281.00K 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $240.00K 10-K · filed 2025-02-27 | |
| 2023-09-30 | $391.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $255.00K 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $137.00K 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $96.00K 10-K · filed 2024-03-21 | |
| 2022-09-30 | $88.00K 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $292.00K 10-Q · filed 2022-08-01 | |
| 2022-03-31 | $95.00K 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $470.00K 10-K · filed 2023-03-15 | |
| 2021-09-30 | $70.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $246.00K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $252.00K 10-Q · filed 2021-04-30 | |
| 2020-12-31 | $383.00K 10-K · filed 2022-03-18 | $57.00K 10-K · filed 2021-03-05 |
| 2020-09-30 | $220.00K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $939.00K 10-Q · filed 2020-08-13 | |
| 2019-12-31 | $143.00K 10-K · filed 2021-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |